Results 11 to 20 of about 34,301 (236)

The state of physical functionning of patients with juvenile idiopathic arthritis in the assessment of quality of life

open access: yesАктуальні проблеми сучасної медицини, 2021
Summary. Juvenile idiopathic arthritis is a severe chronic childhood disease that affects not only the joints but is also accompanied by various comorbid conditions, among which eye damage (uveitis) is the most common. In addition to a significant impact
Ludmila Bogmat   +3 more
doaj   +1 more source

Juvenile Idiopathic Arthritis

open access: yesJournal of Education, Health and Sport, 2021
Młodzieńcze idiopatyczne zapalenie stawów (JIA) jest najczęstszą przewlekłą zapalną chorobą reumatyczną wieku dziecięcego. Jest to niejednorodna grupa chorób charakteryzująca się zapaleniem stawów, cechami pozastawowymi, w tym zapaleniem błony naczyniowej oka oraz, w niektórych przypadkach, markerami laboratoryjnymi.
Aleksandra Strońska   +2 more
openaire   +3 more sources

Experience of use of the anti-cytokine drug adalimumab in children with polyarticular seronegative junior arthritis living in the Samara region

open access: yesЛечащий Врач, 2023
Background. Juvenile idiopathic arthritis is the most common rheumatic disease in childhood. Adalimumab is the drug of choice for polyarthritis, HLA-B27-associated arthritis, psoriatic arthritis, as well as for the association of arthritis with ...
S. V. Plakhotnikova   +3 more
doaj   +1 more source

Risk Factors for the Development of Low Quality of Life in Adults with Juvenile Idiopathic Arthritis

open access: yesGalician Medical Journal, 2018
Juvenile idiopathic arthritis is known to persist into adulthood which is associated with the development of a large number of long-term consequences, including low quality of life.
Marta Dzhus
doaj   +1 more source

Uveitis in Juvenile Idiopathic Arthritis [PDF]

open access: yesDeutsches Ärzteblatt international, 2015
Juvenile idiopathic arthritis (JIA) is the most common systemic disease causing uveitis in childhood, with a prevalence of 10 per 100 000 persons. JIA often takes a severe inflammatory course, and its complications often endanger vision.This review is based on pertinent articles retrieved by a selective literature search up to 18 August 2014 and on the
Heiligenhaus, Arnd   +3 more
openaire   +3 more sources

Association of the CCR5 gene with juvenile idiopathic arthritis [PDF]

open access: yes, 2010
The CC chemokine receptor 5 (CCR5) has been shown to be important in the recruitment of T-helper cells to the synovium, where they accumulate, drive the inflammatory process and the consequent synovitis and joint destruction.
Martin, P.   +22 more
core   +1 more source

Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA) [PDF]

open access: yes, 2012
The cytokine IL-10 and its family members have been implicated in autoimmune diseases and we have previously reported that genetic variants in IL-10 were associated with a rare group of diseases called juvenile idiopathic arthritis (JIA). The aim of this
Bryant, A.   +66 more
core   +1 more source

Juvenile Idiopathic Arthritis Complicated with Atlantoaxial Subluxation: A Case Report

open access: yesTurkish Journal of Internal Medicine, 2022
Juvenile idiopathic arthritis is a rheumatological disease that starts before 16 years and involves joints. Many complications such as bone erosions and joint destruction can be seen in the course of the disease.
Yağmur Çakır   +6 more
doaj   +1 more source

Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis [PDF]

open access: yes, 2010
Recent genetic studies have led to identification of numerous loci that are associated with susceptibility to autoimmune diseases. The strategy of using information from these studies has facilitated the identification of novel juvenile idiopathic ...
Martin, P.   +12 more
core   +1 more source

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

open access: yesPediatric Rheumatology Online Journal, 2010
Recently, the Food and Drug Administration placed a "black box" label on etanercept, and other tumor necrosis factor inhibitors used to treat childhood arthritis, warning of the risk of malignancies.
Cron Randy Q, Beukelman Timothy
doaj   +1 more source

Home - About - Disclaimer - Privacy